Randall T. Schapiro

2.0k total citations
26 papers, 1.3k citations indexed

About

Randall T. Schapiro is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Randall T. Schapiro has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Randall T. Schapiro's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Randall T. Schapiro is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Randall T. Schapiro collaborates with scholars based in United States, United Kingdom and Canada. Randall T. Schapiro's co-authors include Andrew Goodman, Andrew R. Blight, Ron Cohen, Lawrence N. Marinucci, Lauren Krupp, Theodore R. Brown, Steven R. Schwid, Keith R. Edwards, Robert W. Motl and Erin M. Snook and has published in prestigious journals such as The Lancet, Neurology and Annals of Neurology.

In The Last Decade

Randall T. Schapiro

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randall T. Schapiro United States	16	1.0k	470	321	217	116	26	1.3k
Theodore R. Brown United States	12	822 0.8×	305 0.6×	254 0.8×	213 1.0×	93 0.8×	24	1.1k
N. Téllez Spain	11	752 0.7×	337 0.7×	172 0.5×	95 0.4×	88 0.8×	12	932
Rex D. Simmons Australia	20	1.1k 1.0×	155 0.3×	209 0.7×	85 0.4×	163 1.4×	45	1.7k
María José Sá Portugal	19	985 1.0×	297 0.6×	134 0.4×	85 0.4×	157 1.4×	99	1.4k
Bardia Nourbakhsh United States	18	877 0.9×	357 0.8×	164 0.5×	102 0.5×	268 2.3×	58	1.5k
Kyla A. McKay Sweden	21	1.2k 1.1×	287 0.6×	214 0.7×	118 0.5×	119 1.0×	54	1.5k
Dieter Pöhlau Germany	19	728 0.7×	368 0.8×	103 0.3×	83 0.4×	142 1.2×	53	1.3k
Lorena Lorefice Italy	23	956 0.9×	250 0.5×	183 0.6×	92 0.4×	195 1.7×	102	1.5k
Giuseppe Fenu Italy	23	1.0k 1.0×	341 0.7×	168 0.5×	88 0.4×	213 1.8×	92	1.5k
Charles Peter Tilbery Brazil	18	626 0.6×	229 0.5×	149 0.5×	68 0.3×	45 0.4×	74	941

Countries citing papers authored by Randall T. Schapiro

Since Specialization

Citations

This map shows the geographic impact of Randall T. Schapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall T. Schapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall T. Schapiro more than expected).

Fields of papers citing papers by Randall T. Schapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall T. Schapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall T. Schapiro. The network helps show where Randall T. Schapiro may publish in the future.

Co-authorship network of co-authors of Randall T. Schapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Randall T. Schapiro. A scholar is included among the top collaborators of Randall T. Schapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall T. Schapiro. Randall T. Schapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goodman, Andrew, et al.. (2014). A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis. International Journal of MS Care. 16(3). 153–160. 24 indexed citations

Goodman, Andrew, Theodore R. Brown, Keith R. Edwards, et al.. (2010). A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Annals of Neurology. 68(4). 494–502. 246 indexed citations

Lipsy, Robert J., et al.. (2009). Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists. Journal of Managed Care Pharmacy. 15(9 Supp A). 1–18. 8 indexed citations

Goodman, Andrew, Theodore R. Brown, Lauren Krupp, et al.. (2009). Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet. 373(9665). 732–738. 380 indexed citations

Motl, Robert W., Erin M. Snook, & Randall T. Schapiro. (2008). Symptoms and physical activity behavior in individuals with multiple sclerosis. Research in Nursing & Health. 31(5). 466–475. 62 indexed citations

Goodman, Andrew, J. A. Cohen, Lauren Krupp, et al.. (2008). Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 71(15). 1134–1141. 145 indexed citations

Motl, Robert W., Erin M. Snook, & Randall T. Schapiro. (2008). Neurological Impairment as Confounder or Moderater of Association Between Symptoms and Physical Activity in Multiple Sclerosis. International Journal of MS Care. 10(4). 99–105. 8 indexed citations

Schapiro, Randall T.. (2005). Managing symptoms of multiple sclerosis. Neurologic Clinics. 23(1). 177–187. 35 indexed citations

Schapiro, Randall T.. (2001). Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis. Current Neurology and Neuroscience Reports. 1(3). 299–302. 13 indexed citations

10.

Fabio, Rosa Angela, et al.. (1998). Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Archives of Physical Medicine and Rehabilitation. 79(2). 141–146. 96 indexed citations

11.

Nance, Patricia W., W. A. Sheremata, Sharon Lynch, et al.. (1997). Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis. Archives of Neurology. 54(6). 731–736. 61 indexed citations

12.

Young, Robert R., Murat Emre, Patricia W. Nance, Randall T. Schapiro, & Michael Barnes. (1997). CURRENT ISSUES IN SPASTICITY MANAGEMENT. The Neurologist. 3(4). 261–261. 17 indexed citations

13.

Quick, D.C. & Randall T. Schapiro. (1996). Population Dynamics of the Disability Status Scales for Multiple Sclerosis. Neurorehabilitation and neural repair. 10(2). 127–134. 1 indexed citations

14.

Schapiro, Randall T.. (1994). Symptom management in multiple sclerosis. Annals of Neurology. 36(S1). S123–S129. 77 indexed citations

15.

Schapiro, Randall T. & Sara Langer. (1994). Symptomatic therapy of multiple sclerosis. Current Opinion in Neurology. 7(3). 229–233. 18 indexed citations

16.

Schapiro, Randall T.. (1991). Multiple Sclerosis: A Rehabilitation Approach to Management. Medical Entomology and Zoology. 18 indexed citations

17.

Schapiro, Randall T.. (1990). The Rehabilitation of Multiple Sclerosis. Neurorehabilitation and neural repair. 4(4). 215–217. 5 indexed citations

18.

Schapiro, Randall T., et al.. (1989). Primary CNS lymphoma presenting as multiple sclerosis. A case study.. PubMed. 72(3). 157–60. 15 indexed citations

19.

Schapiro, Randall T., et al.. (1984). The Current Management of Multiple Sclerosis. Annals of the New York Academy of Sciences. 436(1). 425–434. 9 indexed citations

20.

Horwitz, Charles A., et al.. (1983). Infectious Mononucleosis in Patients Aged 40 to 72 Years. Medicine. 62(4). 256–256. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact